Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| United States (Primary) | PRIMARYUSA | Univ | 6,183 | 79,893,438 | -1.35% | -0.16% | 4.21% | 6.68% | 12.29% | 24.75% |
| Healthcare | HEALTHCARE | Sector | 1,145 | 6,717,675 | -1.28% | 0.47% | -1.74% | -6.71% | -4.84% | 13.97% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 584 | 3,736,333 | -1.39% | 1.78% | 0.36% | -4.19% | 2.95% | 36.31% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 278 | 1,538,930 | -1.07% | 3.31% | 6.86% | -0.03% | -0.96% | 38.32% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 91 | 166,357 | -1.68% | -0.03% | 5.83% | 12.15% | 22.75% | 59.37% |
Show Stocks
Sort: 1Mo %
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | AXSM:USAAXSM:USA | Stock | 1 | 11,212 | -1.96% | 4.76% | 23.63% | 24.23% | 65.74% | 112.39% |
| Neurocrine Biosciences, Inc. | NBIX:USANBIX:USA | Stock | 1 | 15,795 | -0.40% | 4.05% | 23.37% | 24.00% | 9.89% | 31.72% |
| GH Research PLC | GHRS:USAGHRS:USA | Stock | 1 | 1,466 | -3.69% | -0.14% | 20.57% | 33.77% | 55.90% | 99.91% |
| Catalyst Pharmaceuticals, Inc. | CPRX:USACPRX:USA | Stock | 1 | 3,808 | 0.06% | 0.10% | 20.43% | 26.54% | 35.45% | 31.12% |
| Jazz Pharmaceuticals Plc | JAZZ:USAJAZZ:USA | Stock | 1 | 14,354 | -0.99% | 1.32% | 15.64% | 36.19% | 61.44% | 115.68% |
| Design Therapeutics, Inc. | DSGN:USADSGN:USA | Stock | 1 | 886 | -1.17% | 1.05% | 14.87% | 42.00% | 103.54% | 327.68% |
| Arrowhead Pharmaceuticals, Inc. | ARWR:USAARWR:USA | Stock | 1 | 10,736 | -3.79% | 5.48% | 12.78% | 20.38% | 86.36% | 399.80% |
| Alkermes Plc | ALKS:USAALKS:USA | Stock | 1 | 6,189 | -2.29% | 7.12% | 11.00% | 13.92% | 20.86% | 20.09% |
| Biogen, Inc. | BIIB:USABIIB:USA | Stock | 1 | 28,289 | 0.83% | -0.26% | 9.62% | -1.36% | 17.13% | 55.98% |
| Praxis Precision Medicines, Inc. | PRAX:USAPRAX:USA | Stock | 1 | 9,389 | -0.85% | 3.81% | 6.93% | 4.43% | 92.37% | 820.91% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 91 | 166,357 | -1.68% | -0.03% | 5.83% | 12.15% | 22.75% | 59.37% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,081 | 104,749,087 | -1.20% | 0.21% | 5.35% | 8.54% | 10.62% | 26.62% |
| LB Pharmaceuticals, Inc. | LBRX:USALBRX:USA | Stock | 1 | 850 | -5.57% | -7.23% | 4.88% | 22.97% | 99.06% | N/A |
| Harmony Biosciences Holdings, Inc. | HRMY:USAHRMY:USA | Stock | 1 | 1,733 | -2.18% | -2.90% | 2.28% | -18.50% | -12.25% | -12.09% |
| Soleno Therapeutics, Inc. | SLNO:USASLNO:USA | Stock | 1 | 2,796 | 0.04% | 0.11% | 0.84% | 37.69% | 11.95% | -29.39% |
| MapLight Therapeutics, Inc. | MPLT:USAMPLT:USA | Stock | 1 | 1,254 | -1.91% | 4.85% | 0.77% | 66.55% | 101.19% | N/A |
| ACADIA Pharmaceuticals, Inc. | ACAD:USAACAD:USA | Stock | 1 | 3,610 | -3.12% | -4.46% | 0.71% | -6.75% | -9.48% | 21.59% |
| Supernus Pharmaceuticals, Inc. | SUPN:USASUPN:USA | Stock | 1 | 2,834 | -3.46% | -4.08% | 0.43% | -4.24% | 11.23% | 52.19% |
| Taysha Gene Therapies, Inc. | TSHA:USATSHA:USA | Stock | 1 | 1,712 | -5.40% | -12.48% | 0.17% | 30.13% | 48.63% | 132.81% |
| Edgewise Therapeutics, Inc. | EWTX:USAEWTX:USA | Stock | 1 | 3,550 | -2.71% | -6.31% | -0.09% | 10.01% | 62.05% | 129.00% |
| PTC Therapeutics, Inc. | PTCT:USAPTCT:USA | Stock | 1 | 5,664 | -1.72% | -3.01% | -0.32% | 3.33% | -4.64% | 57.74% |
| Kyverna Therapeutics, Inc. | KYTX:USAKYTX:USA | Stock | 1 | 574 | -11.64% | 1.50% | -0.42% | 25.03% | 46.45% | 335.32% |
| Scholar Rock Holding Corp. | SRRK:USASRRK:USA | Stock | 1 | 5,669 | -3.76% | 1.98% | -1.30% | 6.24% | 64.12% | 60.07% |
| Rapport Therapeutics, Inc. | RAPP:USARAPP:USA | Stock | 1 | 1,709 | -2.32% | -2.55% | -6.25% | 27.56% | 50.26% | 280.01% |
| Definium Therapeutics, Inc. | DFTX:USADFTX:USA | Stock | 1 | 2,289 | -1.69% | -4.81% | -6.54% | 24.20% | 80.48% | 220.46% |
| Xenon Pharmaceuticals, Inc. | XENE:USAXENE:USA | Stock | 1 | 5,190 | -2.88% | -3.63% | -6.91% | 30.56% | 35.84% | 83.94% |
| Prothena Corp. Plc | PRTA:USAPRTA:USA | Stock | 1 | 525 | -1.01% | -9.04% | -7.22% | 8.93% | -4.13% | 45.35% |
| Dianthus Therapeutics, Inc. | DNTH:USADNTH:USA | Stock | 1 | 4,691 | 0.96% | -0.63% | -7.26% | 75.09% | 142.70% | 359.52% |
| Alto Neuroscience, Inc. | ANRO:USAANRO:USA | Stock | 1 | 806 | -2.59% | -5.28% | -11.82% | 19.31% | 102.47% | 845.68% |
| Biohaven Ltd. | BHVN:USABHVN:USA | Stock | 1 | 1,272 | -2.88% | -11.16% | -12.49% | -23.69% | 8.42% | -44.63% |
| Bright Minds Biosciences, Inc. | DRUG:USADRUG:USA | Stock | 1 | 754 | -0.22% | -9.39% | -12.61% | -7.67% | 32.75% | 139.40% |
| Dyne Therapeutics, Inc. | DYN:USADYN:USA | Stock | 1 | 2,798 | -5.42% | -1.82% | -13.16% | 13.15% | -8.18% | 47.27% |
| Stoke Therapeutics, Inc. | STOK:USASTOK:USA | Stock | 1 | 1,873 | -4.08% | -8.54% | -14.88% | -3.25% | 15.38% | 212.36% |
| Capricor Therapeutics, Inc. | CAPR:USACAPR:USA | Stock | 1 | 1,656 | -3.42% | -5.23% | -16.77% | 25.01% | 398.96% | 201.15% |
| Sarepta Therapeutics, Inc. | SRPT:USASRPT:USA | Stock | 1 | 1,839 | -6.05% | -12.05% | -17.10% | -1.85% | -1.52% | -50.24% |
| Solid Biosciences, Inc. | SLDB:USASLDB:USA | Stock | 1 | 681 | -9.31% | -4.81% | -17.52% | 25.82% | 60.93% | 167.18% |
| Annexon, Inc. | ANNX:USAANNX:USA | Stock | 1 | 836 | -2.98% | -8.44% | -17.69% | 3.37% | 94.40% | 187.85% |
| Seaport Therapeutics, Inc. | SPTX:USASPTX:USA | Stock | 1 | 851 | -0.80% | 4.70% | N/A | N/A | N/A | N/A |
* Colors indicate performance relative to the benchmark.